RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva^® Allograft Dermis in Breast Reconstruction

RTI Surgical announced the enrollment of the first patient in ADMIRE. This IDE study is designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.